A. Senning

A. Senning, the surgeon Åke Senning, contributed to the development and evaluation of cardiovascular interventions. The University of Zurich's institutional history describes his technical innovations in cardiac surgery and his appointment to direct Surgical Clinic A in 1961.^[ref]

With A. R. Grüntzig and W. E. Siegenthaler, Senning coauthored the 1979 primary report on coronary angioplasty. The series included cases requiring emergency bypass graft surgery after acute deterioration.^[ref] The joint work connects a catheter-based mechanical intervention with the need to evaluate outcomes beyond its immediate geometric result.

The scientific distinction is between achieving an intended local change and obtaining an acceptable overall outcome. Enlarging a narrowed coronary artery addresses one anatomical objective. Complications, subsequent procedures and later function are additional observations; none is fully encoded by the immediate opening of the vessel.

An original audit example makes the endpoint problem explicit. Suppose 80 of 100 procedures meet a chosen technical-success definition and 10 patients experience a specified adverse event. If $S$ is the technical-success set and $E$ the adverse-event set, thenWithout knowing overlap, the number with technical success and no recorded event can lie between 70 and 80. Subtracting ten assumes every adverse event occurred among technical successes; counting all eighty ignores the overlap question. These are hypothetical counts, not Senning's reported outcomes.

The example explains why procedural development and clinical evaluation need shared, explicit endpoints. Senning's verified contribution here is to the joint primary study; a coauthor list alone does not assign each device modification or clinical observation to one individual.